These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 34580043)
1. Follicular Lymphoma: Refining Prognostic Models and Impact of Pod-24 in Clinical Outcomes. Nogueira DS; Lage LAPC; Culler HF; Pereira J Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):67-75. PubMed ID: 34580043 [TBL] [Abstract][Full Text] [Related]
2. [Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia]. Nesterova ES; Kravchenko SK; Mangasarova YK; Baryakh EA; Misyurina AE; Vorobyev VI; Plastinina LV; Chernova NG; Kovrigina AM; Obukhova TN; Klyasova GA; Shevelev AA; Kostina IE; Gemdzhian EG; Gaponova TV; Vorobyev AI Ter Arkh; 2016; 88(7):62-71. PubMed ID: 27459617 [TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma. Berglund A; Enblad G; Carlson K; Glimelius B; Hagberg H Eur J Haematol; 2000 Jul; 65(1):17-22. PubMed ID: 10914935 [TBL] [Abstract][Full Text] [Related]
4. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760 [TBL] [Abstract][Full Text] [Related]
5. [Follicular lymphoma: first - line selection criteria of treatment]. Nesterova ES; Kravchenko SK; Kovrigina AM; Gemdzhian EG; Plastinina LV; Babaeva FE; Obukhova TN; Magomedova AU; Gaponova TV; Kremenetskaya AM; Vorobyev AI Ter Arkh; 2019 Aug; 91(8):75-83. PubMed ID: 32598757 [TBL] [Abstract][Full Text] [Related]
6. High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS. Deconinck E; Foussard C; Milpied N; Bertrand P; Michenet P; Cornillet-LeFebvre P; Escoffre-Barbe M; Maisonneuve H; Delwail V; Gressin R; Legouffe E; Vilque JP; Desablens B; Jaubert J; Ramee JF; Jenabian A; Thyss A; Le Pourhiet-Le Mevel A; Travade P; Delepine R; Colombat P; Blood; 2005 May; 105(10):3817-23. PubMed ID: 15687232 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR. Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927 [TBL] [Abstract][Full Text] [Related]
8. Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy. Murakami S; Kato H; Higuchi Y; Yamamoto K; Yamamoto H; Saito T; Taji H; Yatabe Y; Nakamura S; Kinoshita T Ann Hematol; 2016 Aug; 95(8):1259-69. PubMed ID: 27220639 [TBL] [Abstract][Full Text] [Related]
9. Advances in Treatment of Follicular Lymphoma. Luminari S; Trotman J; Federico M Cancer J; 2020; 26(3):231-240. PubMed ID: 32496456 [TBL] [Abstract][Full Text] [Related]
10. Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study. Casulo C; Byrtek M; Dawson KL; Zhou X; Farber CM; Flowers CR; Hainsworth JD; Maurer MJ; Cerhan JR; Link BK; Zelenetz AD; Friedberg JW J Clin Oncol; 2015 Aug; 33(23):2516-22. PubMed ID: 26124482 [TBL] [Abstract][Full Text] [Related]
11. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival. Găman AM Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311 [TBL] [Abstract][Full Text] [Related]
12. Does Up-front Autologous Stem-Cell Transplantation at First Relapse Improve Outcome in Transplant-Eligible Follicular Lymphoma Patients Whose Disease Relapses Within 24 Months? Yahya A; Radhwi O; Sobh M; Huebsch L; MacDonald D Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e423-e427. PubMed ID: 33558203 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era. Sesques P; Bourcier J; Golfier C; Lebras L; Nicolas-Virelizier E; Hacini M; Perrin MC; Voillat L; Bachy E; Traverse-Glehen A; Moreau A; Martin L; Ramla S; Casasnovas O; Le Gouill S; Salles G; Ghesquières H Hematol Oncol; 2020 Apr; 38(2):137-145. PubMed ID: 31953963 [TBL] [Abstract][Full Text] [Related]
14. Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial. Sarkozy C; Trneny M; Xerri L; Wickham N; Feugier P; Leppa S; Brice P; Soubeyran P; Gomes Da Silva M; Mounier C; Offner F; Dupuis J; Caballero D; Canioni D; Paula M; Delarue R; Zachee P; Seymour J; Salles G; Tilly H J Clin Oncol; 2016 Aug; 34(22):2575-82. PubMed ID: 27298402 [TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy followed by autologous and allogeneic hematopoietic stem cell transplantation in patients with follicular non-Hodgkin’s lymphoma in the rituximab era. Escobar IG; Sánchez de Ibarguen BC; de Juan VC; Alonso CM; García MM; Ruíz AC; Pulla MP Tumori; 2015; 101(1):2-7. PubMed ID: 25702654 [TBL] [Abstract][Full Text] [Related]
17. Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group. Jurinovic V; Metzner B; Pfreundschuh M; Schmitz N; Wandt H; Keller U; Dreger P; Dreyling M; Hiddemann W; Unterhalt M; Hoster E; Weigert O Biol Blood Marrow Transplant; 2018 Jun; 24(6):1172-1179. PubMed ID: 29605716 [TBL] [Abstract][Full Text] [Related]
18. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults. Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N Cochrane Database Syst Rev; 2012 Jan; 1(1):CD007678. PubMed ID: 22258971 [TBL] [Abstract][Full Text] [Related]